The American Association for the Study of Liver Diseases surveillance guidelines recommend ultrasound surveillance with or without alpha-fetoprotein testing on a semi-annual basis in anyone with cirrhosis because of demonstrated improvements in survival. The gene discussed is AFP; the disease is liver disorder.